Trevor Berry,
DC, DACNB
Dr. Berry was born and raised in Alberta, Canada. He completed his pre-medicine requisites at the University of Calgary and went on to complete his Doctorate at Parker University in Dallas, Texas where he graduated Magna Cum Laude and Salutatorian. He became a board-certified Chiropractic Neurologist in 2000 through ACNB and has over 3500 hours in post-doctoral studies in integrative neurology, functional medicine, and low-level laser therapy. He is involved in multiple laser studies and has been the principal investigator for Level 1 FDA clearances. He was awarded the 2014 researcher of the year for Erchonia lasers. He is the founder of Arizona Chiropractic Neurology Center and has been in practice since 1997 in Chandler, AZ. As an international speaker since 2010, he lectures on nutrition and functional medicine, laboratory testing, neurological diagnostic testing, functional neurology and low-level laser therapy. Dr. Berry co-founded BTB Health Systems and was hired as the Chief Clinical Officer for Applied Functional Neurology (AFN) in 2022.
Because lasers profoundly influenced his own health status and family, Dr. Berry has dedicated himself to bringing innovative non-thermal laser applications to the health care system and was one of the pioneers of brain-based laser therapies for neurological disorders. He takes a fully integrative approach to complex neurological conditions in order to help those with difficult cases or are looking for brain-body optimization. Dr. Berry’s expertise stems from a deep personal interest to find ways that would help him work conditions afflicting the brain and nervous system which controls all other functions of the human body.
Course Outline:
November 7th, 2025 - Friday 11:15am - 2:15pm (LUNCH BREAK 12:15pm-1:15pm)
This course explores how pathogens and adipose contribute to systemic inflammation, neurodegeneration, and chronic pain through mechanisms such as immune priming, molecular mimicry, the brain-gut axis and blood-brain barrier disruption. We will highlight emerging research connecting periodontal and other pathogens to Alzheimer's, Parkinson’s, cardiovascular disease, and chronic musculoskeletal pain. Participants will learn how Erchonia low-level laser therapy (LLLT) offers a non-invasive solution to reduce microbial burden, modulate immune responses, reduce chronic inflammation and restore neurological balance.
5 KEY TAKEAWAYS
-
Oral and Systemic Pathogens Are Neuroinflammatory Triggers Periodontal pathogens such as P. gingivalis and F. nucleatum have been directly implicated in Alzheimer’s disease, Parkinson’s, and chronic systemic inflammation.
-
The Adipose tissue and the effect of Obesity on Brain Why using lasers for adipose reduction can protect against neurodegeneration conditions such as Alzheimer's disease. We will expand on gut concepts and the brain-gut axis.
-
Low-Level Laser Therapy Reduces Pathogenic Load Various laser wavelengths have been shown to reduce bacterial biofilms and inflammation without antibiotics or tissue damage.
-
LLLT Modulates Immune and Neurological Pathways Laser therapy downregulates NF-κB and inflammatory cytokines, upregulates mitochondrial repair, and supports vagal tone—key for managing pain and autoimmunity.
-
Dentists and Physicians Can Disrupt Neuroinflammatory Loops at the Source By addressing oral pathogens with Erchonia lasers, clinicians have a new tool to help patients with early cognitive decline, chronic fatigue, and unresolved pain. We will also touch on lasers as a safe, effective and researched alternative for pain management.